EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Elston George
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%), etc.
EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%), etc.
EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Adage Capital Management, L.P.
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Paggiarino Dario A.
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ribeiro Ramiro
EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Ribeiro Ramiro
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.
EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(6.1%),Peter Kolchinsky(6.1%), etc.
EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(5.6%)
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lurker Nancy
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Elston George
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones David Scott
EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Paggiarino Dario A.
EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%), etc.
No Data